Augmentin and Calpol regained their place amongst the top five brands in the Indian Pharmaceuticals Market (IPM). Our promoted portfolio also ...
Read more: GSK Pharma rises after Q2 PAT jumps 76% YoY | Business Standard News
Sunday, October 31, 2021
Pharma Reviews: Sun Pharma: No plans to get into vaccine production as it requires separate manufacturing infra
Commenting on the US business, he said the drug firm's current generic pipeline for the US market includes 94 abbreviated new drug applications (ANDAs) ...
Read more: Sun Pharma: No plans to get into vaccine production as it requires separate manufacturing infra
Read more: Sun Pharma: No plans to get into vaccine production as it requires separate manufacturing infra
Pharma Reviews: Indian pharma industry needs to address challenges from climate change: PSA VijayRaghavan
She also mentioned the government of India's support to the pharma industry through the Production Linked Incentive Scheme (PLI) scheme to innovate ...
Read more: Indian pharma industry needs to address challenges from climate change: PSA VijayRaghavan
Read more: Indian pharma industry needs to address challenges from climate change: PSA VijayRaghavan
Pharma Reviews: Indian pharma industry needs to address climate change challenges: Principal Scientific Adviser
NEW DELHI : India's pharma industry should gear up to address challenges arising out of climate change, biodiversity and environmental impacts, ...
Read more: Indian pharma industry needs to address climate change challenges: Principal Scientific Adviser
Read more: Indian pharma industry needs to address climate change challenges: Principal Scientific Adviser
Pharma Reviews: Indian-origin pharma CEO shot dead by gunman in US for robbery - Medical Dialogues
New York: An Indian-origin top executive of a pharmaceutical company in the US state of New Jersey was shot dead by a gunman who followed him home ...
Read more: Indian-origin pharma CEO shot dead by gunman in US for robbery - Medical Dialogues
Read more: Indian-origin pharma CEO shot dead by gunman in US for robbery - Medical Dialogues
Saturday, October 30, 2021
Pharma Reviews: Rockwell Automation India Concludes “India Inc. On The Move,” Aims To Make India Global ...
The focus was on 5 key industries namely pharmaceuticals, chemical, automobiles, FMCG, and heavy industries. Reimagining pharma as an innovation hub.
Read more: Rockwell Automation India Concludes “India Inc. On The Move,” Aims To Make India Global ...
Read more: Rockwell Automation India Concludes “India Inc. On The Move,” Aims To Make India Global ...
Pharma Reviews: Indian-origin pharma CEO shot dead by gunman in US for robbery - The Economic Times
Sree Ranga Aravapalli, 54, a resident of New Jersey's Plainsboro, was killed shortly after arriving home by a gunman who, according to authorities ...
Read more: Indian-origin pharma CEO shot dead by gunman in US for robbery - The Economic Times
Read more: Indian-origin pharma CEO shot dead by gunman in US for robbery - The Economic Times
Pharma Reviews: Panel Discussion: Trends in Lab Design - Express Pharma
... Assistant Director- Analytical Science Division-Biology (ASD-Bio), Shriram Institute for Industrial Research, New Delhi India
Read more: Panel Discussion: Trends in Lab Design - Express Pharma
Read more: Panel Discussion: Trends in Lab Design - Express Pharma
Friday, October 29, 2021
Pharma Reviews: Cadila Healthcare gains after strong Q2 results | Business Standard News
Cadila is headquartered in Ahmedabad, India, and ranks 4th in the Indian pharmaceutical industry. The group has manufacturing sites and research ...
Read more: Cadila Healthcare gains after strong Q2 results | Business Standard News
Read more: Cadila Healthcare gains after strong Q2 results | Business Standard News
Pharma Reviews: GSK Pharma net profit rises over two-folds to ₹204 cr in Sept quarter - Mint
GlaxoSmithKline (GSK) Pharmaceuticals saw its consolidated net profit rise ... the top five brands in the Indian Pharmaceuticals Market (1PM).
Read more: GSK Pharma net profit rises over two-folds to ₹204 cr in Sept quarter - Mint
Read more: GSK Pharma net profit rises over two-folds to ₹204 cr in Sept quarter - Mint
Pharma Reviews: GSK Pharma Q3 results: Net profit jumps over two-folds to Rs 204 cr - The Economic Times
Augmentin and Calpol regained their place amongst the top five brands in the Indian Pharmaceuticals Market (1PM). Our promoted portfolio also ...
Read more: GSK Pharma Q3 results: Net profit jumps over two-folds to Rs 204 cr - The Economic Times
Read more: GSK Pharma Q3 results: Net profit jumps over two-folds to Rs 204 cr - The Economic Times
Pharma Reviews: GSK Pharma Q3 Net Profit Jumps Over Two-folds To Rs 204 Crore - Moneycontrol
Augmentin and Ca/pol regained their place amongst the top five brands in the Indian Pharmaceuticals Market (1PM). Our promoted portfolio also ...
Read more: GSK Pharma Q3 Net Profit Jumps Over Two-folds To Rs 204 Crore - Moneycontrol
Read more: GSK Pharma Q3 Net Profit Jumps Over Two-folds To Rs 204 Crore - Moneycontrol
US FDA News: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age
FDA authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age.
Read more: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age
Read more: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age
Pharma Reviews: Stock market update: Nifty Pharma index advances 0.72% - The Economic Times
Shares of Esab India, Bharat Bijlee, Canara Bank , Pioneer Distil and Triveni Turbine hit their fresh 52-week highs in today's trade, while Suvidhaa ...
Read more: Stock market update: Nifty Pharma index advances 0.72% - The Economic Times
Read more: Stock market update: Nifty Pharma index advances 0.72% - The Economic Times
Pharma Reviews: Make in India: German Ambassador visits SCHOTT tubing plant in Jambusar, Gujarat ...
This is a perfect example of 'Make in India' and 'Industry 4.0'. ... supply to the Indian pharma industry as well as neighbouring countries.”.
Read more: Make in India: German Ambassador visits SCHOTT tubing plant in Jambusar, Gujarat ...
Read more: Make in India: German Ambassador visits SCHOTT tubing plant in Jambusar, Gujarat ...
Pharma Reviews: We trust Indian industry, Bharat Biotech has been submitting data regularly ... - Medical Dialogues
United Nations/Geneva: India's Bharat Biotech has been submitting data on the EUL of Covaxin "regularly and very quickly" to a technical committee ...
Read more: We trust Indian industry, Bharat Biotech has been submitting data regularly ... - Medical Dialogues
Read more: We trust Indian industry, Bharat Biotech has been submitting data regularly ... - Medical Dialogues
Pharma Reviews: Panel Discussion: Next Gen Pharma Labs: Techniques, Technology and Adapting to rapid ...
+ As the Pharma sector becomes more systems-oriented, automation and ... But India Pharma Inc will turn challenges into learnings and ...
Read more: Panel Discussion: Next Gen Pharma Labs: Techniques, Technology and Adapting to rapid ...
Read more: Panel Discussion: Next Gen Pharma Labs: Techniques, Technology and Adapting to rapid ...
Pharma Reviews: Balaxi Pharma develops strategy to expand its portfolio of proprietary and niche branded ...
Balaxi Pharmaceuticals has committed to backward integration for manufacturing new market-specific differentiated formulations that will serve to ...
Read more: Balaxi Pharma develops strategy to expand its portfolio of proprietary and niche branded ...
Read more: Balaxi Pharma develops strategy to expand its portfolio of proprietary and niche branded ...
US FDA News: Datascope/Getinge/Maquet Recalls Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pump Battery Packs Due to Risk of Battery Failure
Battery packs are used with the Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pump to inflate and deflate intra-aortic balloons that support the left ventricle. The packs are relied on when AC power is not available.
Read more: Datascope/Getinge/Maquet Recalls Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pump Battery Packs Due to Risk of Battery Failure
Read more: Datascope/Getinge/Maquet Recalls Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pump Battery Packs Due to Risk of Battery Failure
US FDA News: Zimmer Biomet Recalls ROSA One 3.1 Brain Application Due to Error in Software
The ROSA One 3.1 Brain Application is a device that helps position and orient instrument holders or tool guides using the ROSA One 3.1 Brain Application software.
Read more: Zimmer Biomet Recalls ROSA One 3.1 Brain Application Due to Error in Software
Read more: Zimmer Biomet Recalls ROSA One 3.1 Brain Application Due to Error in Software
Pharma Reviews: Hiring of manpower still under process for drug price violation cells despite fund allocation ...
PMRUs have been tasked with collection and compilation of market based data and also to collect test samples of medicines.
Read more: Hiring of manpower still under process for drug price violation cells despite fund allocation ...
Read more: Hiring of manpower still under process for drug price violation cells despite fund allocation ...
Pharma Reviews: Zydus Cadila posts business growth of 12% in human health formulations with revenues of ...
The company's India business which comprises human formulations and ... on the account of sale of animal health established market undertaking, ...
Read more: Zydus Cadila posts business growth of 12% in human health formulations with revenues of ...
Read more: Zydus Cadila posts business growth of 12% in human health formulations with revenues of ...
Pharma Reviews: 147 stocks hit highs, 37 scrips at new lows amid volatility - The Financial Express
Indian share market benchmarks were trading volatile, where BSE Sensex and ... Generic Pharmasec, Getalong Enterprise, Indian Bright Steel Co., ...
Read more: 147 stocks hit highs, 37 scrips at new lows amid volatility - The Financial Express
Read more: 147 stocks hit highs, 37 scrips at new lows amid volatility - The Financial Express
Pharma Reviews: We trust Indian industry, Bharat Biotech has been submitting data regularly, very quickly ...
Promo Mailers, Receive information about events, industry, etc. ... Technological Disruption in Indian Health & Pharma ...
Read more: We trust Indian industry, Bharat Biotech has been submitting data regularly, very quickly ...
Read more: We trust Indian industry, Bharat Biotech has been submitting data regularly, very quickly ...
Pharma Reviews: Market LIVE Updates: Indices recover, trade flat; pharma, metal, PSU banks in focus - Moneycontrol
Indian Railway Catering and Tourism Corp (IRCTC) share price locked at 20 percent lower circuit on October 29 after the railway ministry asked the ...
Read more: Market LIVE Updates: Indices recover, trade flat; pharma, metal, PSU banks in focus - Moneycontrol
Read more: Market LIVE Updates: Indices recover, trade flat; pharma, metal, PSU banks in focus - Moneycontrol
Pharma Reviews: Indian cos asked to bid for molnupiravir deal - Mint
Companies such as Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr. Reddy's Laboratories, Hetero Pharma, Natco Pharma, and Optimus Pharma are in ...
Read more: Indian cos asked to bid for molnupiravir deal - Mint
Read more: Indian cos asked to bid for molnupiravir deal - Mint
Pharma Reviews: Share Market LIVE: Sensex rises over 900 pts from day's low, tops 60000, Nifty reclaims 17900
Share Market News Today | Sensex, Nifty, Share Prices LIVE: Domestic equity ... Exide Industries, GAIL (India), Glaxosmithkline Pharmaceuticals, ...
Read more: Share Market LIVE: Sensex rises over 900 pts from day's low, tops 60000, Nifty reclaims 17900
Read more: Share Market LIVE: Sensex rises over 900 pts from day's low, tops 60000, Nifty reclaims 17900
Pharma Reviews: We trust Indian industry, Bharat Biotech has been submitting data regularly, very quickly
Business News › Industry › Healthcare/Biotech › Pharmaceuticals ›We trust ... We trust Indian industry, Bharat Biotech has been submitting data ...
Read more: We trust Indian industry, Bharat Biotech has been submitting data regularly, very quickly
Read more: We trust Indian industry, Bharat Biotech has been submitting data regularly, very quickly
Pharma Reviews: molnupiravir: Natco Pharma, Hetero seek marketing authorisation for anti-Covid drug ...
In India, Merck & Co. has signed voluntary licensing agreements with Cipla Ltd, Dr Reddy's Laboratories, Emcure Pharmaceuticals Ltd, Hetero Labs ...
Read more: molnupiravir: Natco Pharma, Hetero seek marketing authorisation for anti-Covid drug ...
Read more: molnupiravir: Natco Pharma, Hetero seek marketing authorisation for anti-Covid drug ...
Pharma Reviews: Keynote Address: Dr Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, Indian ...
+ Pharma companies have to plan for contingencies and build new capabilites to survive and thrive in a complex and volatile environment
Read more: Keynote Address: Dr Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, Indian ...
Read more: Keynote Address: Dr Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, Indian ...
Pharma Reviews: Make India manufacturing hub: Mansukh Mandaviya urges Pharma industry - Medical Dialogues
New Delhi: Union Chemicals and Fertilisers Minister Mansukh Mandaviya on Wednesday urged the pharma industry to make India manufacturing hub as ...
Read more: Make India manufacturing hub: Mansukh Mandaviya urges Pharma industry - Medical Dialogues
Read more: Make India manufacturing hub: Mansukh Mandaviya urges Pharma industry - Medical Dialogues
Pharma Reviews: Wipro's Azim Premji donated Rs 27 crore per day in FY21, retains top giver rank
Mukesh Ambani of Reliance Industries, India's richest man by a ... The pharma industry has the largest number of philanthropists followed by ...
Read more: Wipro's Azim Premji donated Rs 27 crore per day in FY21, retains top giver rank
Read more: Wipro's Azim Premji donated Rs 27 crore per day in FY21, retains top giver rank
Pharma Reviews: Balaji Amines tumbles as Q2 PAT slips 11.76% QoQ to Rs 79.75 cr | Business Standard News
Capital Market | | Last Updated at October 28 2021 14:50 IST ... as the dependability on Indian pharma and agrochemicals industry increases on ...
Read more: Balaji Amines tumbles as Q2 PAT slips 11.76% QoQ to Rs 79.75 cr | Business Standard News
Read more: Balaji Amines tumbles as Q2 PAT slips 11.76% QoQ to Rs 79.75 cr | Business Standard News
Pharma Reviews: Bharat Biotech's US partner Ocugen files request with FDA for Covaxin trials - Express Pharma
By Press Trust of India Last updated Oct 28, 2021 ... PLI scheme for pharma sector has potential to make India a pharma hub: Mandaviya. Next Post.
Read more: Bharat Biotech's US partner Ocugen files request with FDA for Covaxin trials - Express Pharma
Read more: Bharat Biotech's US partner Ocugen files request with FDA for Covaxin trials - Express Pharma
Pharma Reviews: Medicines, raw material prices to take hit amid looming power crisis in China | Zee Business
According to the industry, the prices of Active Pharmaceutical Ingredients ... Indian pharmaceutical companies can import up to 70 per cent of raw ...
Read more: Medicines, raw material prices to take hit amid looming power crisis in China | Zee Business
Read more: Medicines, raw material prices to take hit amid looming power crisis in China | Zee Business
Pharma Reviews: Success Story of Healing Pharma India Pvt. Ltd. - Mid-Day
Healing entered the market with the Flagship product “Luliconaz – Anit fungal cream” which received immense acceptance and the sales were peaked in a ...
Read more: Success Story of Healing Pharma India Pvt. Ltd. - Mid-Day
Read more: Success Story of Healing Pharma India Pvt. Ltd. - Mid-Day
Pharma Reviews: Despite India-China border disputes, trade dealings persist | The Avenue Mail
Despite India's pharma sector earning billions of rupees every year by selling its medicines in the country and abroad, about 85% of the active ...
Read more: Despite India-China border disputes, trade dealings persist | The Avenue Mail
Read more: Despite India-China border disputes, trade dealings persist | The Avenue Mail
Thursday, October 28, 2021
Pharma Reviews: Power crisis brewing in China likely to hit Indian pharma companies | Business Standard News
Read more about Power crisis brewing in China likely to hit Indian pharma companies on Business-standard. Delays in consignments, rising prices of ...
Read more: Power crisis brewing in China likely to hit Indian pharma companies | Business Standard News
Read more: Power crisis brewing in China likely to hit Indian pharma companies | Business Standard News
Pharma Reviews: PLI scheme for pharma sector has potential to make India a pharma hub: Mandaviya ...
This will create demand for more drugs and medical devices, which will benefit the pharma industries in India. Welcoming all the industry captains and ...
Read more: PLI scheme for pharma sector has potential to make India a pharma hub: Mandaviya ...
Read more: PLI scheme for pharma sector has potential to make India a pharma hub: Mandaviya ...
Pharma Reviews: Dr Lal gets Suburban into its fold, says acquisitions crucial for growth in diagnostics
This is after the promoters of Mankind, yet another Indian pharma ... Dr Lal feels it has to be viewed in the light of the fact India's size and ...
Read more: Dr Lal gets Suburban into its fold, says acquisitions crucial for growth in diagnostics
Read more: Dr Lal gets Suburban into its fold, says acquisitions crucial for growth in diagnostics
Pharma Reviews: Mansukh Mandaviya urges pharma industry to make India a manufacturing hub
In 2020, FDI in the pharma sector increased 98 per cent year on year and in the in the last financial year exports from India also grew by 18 per ...
Read more: Mansukh Mandaviya urges pharma industry to make India a manufacturing hub
Read more: Mansukh Mandaviya urges pharma industry to make India a manufacturing hub
Pharma Reviews: India largest generic medicine supplier in world: Mandaviya - Nagaland Post
“Pharma sector is our religion, we believe in the concept of 'Vasudhaiva Kutumbakam”, said the Minister. Addressing an Investor Summit virtually ...
Read more: India largest generic medicine supplier in world: Mandaviya - Nagaland Post
Read more: India largest generic medicine supplier in world: Mandaviya - Nagaland Post
Pharma Reviews: Union Health Minister addresses pharma & medtech opportunities at Investor Summit
“PLI scheme for the Pharma sector will give a boost to the industry and has potential to make India a Pharma hub”: Dr Mansukh Mandaviya.
Read more: Union Health Minister addresses pharma & medtech opportunities at Investor Summit
Read more: Union Health Minister addresses pharma & medtech opportunities at Investor Summit
Pharma Reviews: SCHOTT glass responsible for almost 95 pc of COVID-19 vaccine packaging in India: German envoy
This is a perfect example of 'Make in India' and 'Industry 4.0'. ... to the Indian pharma industry as well as neighbouring countries," he said.
Read more: SCHOTT glass responsible for almost 95 pc of COVID-19 vaccine packaging in India: German envoy
Read more: SCHOTT glass responsible for almost 95 pc of COVID-19 vaccine packaging in India: German envoy
Wednesday, October 27, 2021
Pharma Reviews: Mansukh Mandaviya says 'centre is pro-farmer but industry-friendly' at Investors Summit
Spoke about our Govt's pro-industry reforms & efforts to make India the best ... "Opportunities and Partnerships in Pharmaceuticals and Medical ...
Read more: Mansukh Mandaviya says 'centre is pro-farmer but industry-friendly' at Investors Summit
Read more: Mansukh Mandaviya says 'centre is pro-farmer but industry-friendly' at Investors Summit
Pharma Reviews: India to become best investment destination for pharma sector: Mandaviya - The Statesman
This would create demand for more drugs and medical devices, which would benefit the pharma industries in India. SNS | New Delhi | October 27, ...
Read more: India to become best investment destination for pharma sector: Mandaviya - The Statesman
Read more: India to become best investment destination for pharma sector: Mandaviya - The Statesman
Pharma Reviews: Despite India-China border disputes, trade dealings persist
The outbreak of the COVID-19 pandemic provided the Indian pharmaceutical sector with a unique opportunity to make itself self-reliant.
Read more: Despite India-China border disputes, trade dealings persist
Read more: Despite India-China border disputes, trade dealings persist
Pharma Reviews: Torrent Pharma Q2 Review - Better Show In India, Brazil Offset By Weak U.S. Sales: Motilal Oswal
These reports offer BloombergQuint's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Read more: Torrent Pharma Q2 Review - Better Show In India, Brazil Offset By Weak U.S. Sales: Motilal Oswal
Read more: Torrent Pharma Q2 Review - Better Show In India, Brazil Offset By Weak U.S. Sales: Motilal Oswal
Pharma Reviews: Mandaviya Urges Pharma Industry To Make India A Manufacturing Hub - BW Businessworld
The minister spoke about the government's pro-industry reforms and efforts to make India the best investment destination in the world., ...
Read more: Mandaviya Urges Pharma Industry To Make India A Manufacturing Hub - BW Businessworld
Read more: Mandaviya Urges Pharma Industry To Make India A Manufacturing Hub - BW Businessworld
US FDA News: Windstone Medical Packaging dba Aligned Medical Solutions Issues Nationwide Recall of Cardinal Health’s Monoject™ Flush Prefilled Saline Syringes Placed Into the Following Kits; AMS-9041CP Leaderflex Insertion Kit With Ultrasound, AMS-9046CP-1 Insertion Tray-RX, AMS8939A Universal Procedure Pack w/S
Aligned Medical Solutions initiated a nationwide recall of Cardinal Health’s Monoject™ Flush Prefilled Saline Syringes placed into 9,378 kits. These convenience kits have been found to contain the Cardinal Health’s Monoject™ Flush Prefilled Saline Syringe part # 8881570121, which has been recalled f
Read more: Windstone Medical Packaging dba Aligned Medical Solutions Issues Nationwide Recall of Cardinal Health’s Monoject™ Flush Prefilled Saline Syringes Placed Into the Following Kits; AMS-9041CP Leaderflex Insertion Kit With Ultrasound, AMS-9046CP-1 Insertion Tray-RX, AMS8939A Universal Procedure Pack w/S
Read more: Windstone Medical Packaging dba Aligned Medical Solutions Issues Nationwide Recall of Cardinal Health’s Monoject™ Flush Prefilled Saline Syringes Placed Into the Following Kits; AMS-9041CP Leaderflex Insertion Kit With Ultrasound, AMS-9046CP-1 Insertion Tray-RX, AMS8939A Universal Procedure Pack w/S
US FDA News: FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
FDA, NIH, 10 pharmaceutical companies and five non-profit organizations have partnered to accelerate development of gene therapies for the 30 million Americans who suffer from a rare disease.
Read more: FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
Read more: FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
US FDA News: FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants
FDA took actions with new orders and labeling for all approved breast implants and updated post-approval study data.
Read more: FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants
Read more: FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants
US FDA News: artnaturals® Issues Voluntary Recall of Limited Batches of 8oz Bottles of Scent Free Hand Sanitizer Due to Presence of Impurities
atnaturals is voluntarily recalling ten manufacturing lots of artnaturals 8oz Scent Free Hand Sanitizer. FDA testing identified 8oz bottles of Scent Free Hand Sanitizer from a single manufacturing lot: G20128A, contained several impurities. Upon being contacted by the FDA, artnaturals responded imm
Read more: artnaturals® Issues Voluntary Recall of Limited Batches of 8oz Bottles of Scent Free Hand Sanitizer Due to Presence of Impurities
Read more: artnaturals® Issues Voluntary Recall of Limited Batches of 8oz Bottles of Scent Free Hand Sanitizer Due to Presence of Impurities
US FDA News: FDA In Brief: FDA Collaborates with Health Canada and UK’s MHRA to Foster Good Machine Learning Practice
Today, FDA, Health Canada and the UK’s MHRA jointly issued the “Good Machine Learning Practice for Medical Device Development: Guiding Principles” to identify a set of ten guiding principles that are important to be included in the development of Good Machine Learning Practice (GMLP).
Read more: FDA In Brief: FDA Collaborates with Health Canada and UK’s MHRA to Foster Good Machine Learning Practice
Read more: FDA In Brief: FDA Collaborates with Health Canada and UK’s MHRA to Foster Good Machine Learning Practice
Pharma Reviews: IITs launch new BTech programmes to become 'industry-ready' | Education News,The Indian Express
There are hundreds of emerging areas but a lot of discussions with chemistry industries, pharma companies and polymer industry went into ...
Read more: IITs launch new BTech programmes to become 'industry-ready' | Education News,The Indian Express
Read more: IITs launch new BTech programmes to become 'industry-ready' | Education News,The Indian Express
Pharma Reviews: India largest generic medicine supplier in world: Mandaviya - Lokmat News English
"Pharma sector is our religion, we believe in the concept of 'Vasudhaiva Kutumbakam", said the Minister. Addressing an Investor Summit virtually on ' ...
Read more: India largest generic medicine supplier in world: Mandaviya - Lokmat News English
Read more: India largest generic medicine supplier in world: Mandaviya - Lokmat News English
Pharma Reviews: Gilead and Merck initiate phase-II study on Lenacapavir and Islatravir oral combo for HIV-1 ...
He added, “This innovative research collaboration builds on the efforts of both companies to help make the end of the epidemic a reality through ...
Read more: Gilead and Merck initiate phase-II study on Lenacapavir and Islatravir oral combo for HIV-1 ...
Read more: Gilead and Merck initiate phase-II study on Lenacapavir and Islatravir oral combo for HIV-1 ...
Pharma Reviews: Mansukh Mandaviya Urges Pharma Industry To Make India A Manufacturing Hub - Moneycontrol
Addressing the Investor Summit on 'Opportunities & Partnerships in Pharma & Medical Devices', the minister spoke about the government's pro-industry ...
Read more: Mansukh Mandaviya Urges Pharma Industry To Make India A Manufacturing Hub - Moneycontrol
Read more: Mansukh Mandaviya Urges Pharma Industry To Make India A Manufacturing Hub - Moneycontrol
Pharma Reviews: Indian businesses turning bullish: NCAER - Fortune India
With Covid-19 infections abating in India, the sentiment across business size, ownership and sector is reinvigorating, reads a survey by an ...
Read more: Indian businesses turning bullish: NCAER - Fortune India
Read more: Indian businesses turning bullish: NCAER - Fortune India
Pharma Reviews: Cipla announces Q2 FY22 results - Express Pharma
▫One India: Overall business grew by 16% YoY on high FY21 base led by ... Cipla's TRx market share stood at 18.2% of the generic market and 14.6% ...
Read more: Cipla announces Q2 FY22 results - Express Pharma
Read more: Cipla announces Q2 FY22 results - Express Pharma
Pharma Reviews: Cipla Health develops povidone iodine-based anti-viral nasal spray effective against ...
Express Pharma, first published as Express Pharma Pulse in 1994, is today India's leading business fortnightly for the pharmaceutical industry.
Read more: Cipla Health develops povidone iodine-based anti-viral nasal spray effective against ...
Read more: Cipla Health develops povidone iodine-based anti-viral nasal spray effective against ...
Tuesday, October 26, 2021
Pharma Reviews: Mansukh Mandaviya to address Investor Summit today - IndiaTV News
The summit will provide an opportunity for industry participants and discuss success stories from the Indian medical devices sector, end to end ...
Read more: Mansukh Mandaviya to address Investor Summit today - IndiaTV News
Read more: Mansukh Mandaviya to address Investor Summit today - IndiaTV News
Pharma Reviews: Should You Apply for Sigachi Industries' IPO? - Investing.com
The Indian foods and beverage market as well as the pharmaceutical market are growing rapidly. However, Sigachi has a lot of competition from the ...
Read more: Should You Apply for Sigachi Industries' IPO? - Investing.com
Read more: Should You Apply for Sigachi Industries' IPO? - Investing.com
Pharma Reviews: Why techies are leaving the Indian IT majors - Fortune India
As employees voluntarily quit their jobs in large numbers, the attrition rate in top-tier Indian IT companies were in double digits during the ...
Read more: Why techies are leaving the Indian IT majors - Fortune India
Read more: Why techies are leaving the Indian IT majors - Fortune India
Pharma Reviews: Teji Mandi Explains: Has Pharma reached its peak or preparing to bounce back?
The pharmaceutical industry is one sector that will never go out of demand. ... This is the biggest problem for Indian pharma companies.
Read more: Teji Mandi Explains: Has Pharma reached its peak or preparing to bounce back?
Read more: Teji Mandi Explains: Has Pharma reached its peak or preparing to bounce back?
Pharma Reviews: Indian excipient manufacturers raise alarm over surging prices of ... - The Financial Express
The Indian excipient industry, which is majorly represented by MSMEs, ... surging prices of excipients by 30% to 50% to impact pharma industry ...
Read more: Indian excipient manufacturers raise alarm over surging prices of ... - The Financial Express
Read more: Indian excipient manufacturers raise alarm over surging prices of ... - The Financial Express
Pharma Reviews: Stock market update: Nifty Pharma index advances 0.19% - The Economic Times
The Nifty Pharma index closed 0.19 per cent up at 13970.65. ... The USD7 billion question that can make or break India's online gaming industry.
Read more: Stock market update: Nifty Pharma index advances 0.19% - The Economic Times
Read more: Stock market update: Nifty Pharma index advances 0.19% - The Economic Times
US FDA News: Coronavirus (COVID-19) Update: October 26, 2021
Coronavirus (COVID-19) Update: October 26, 2021
Read more: Coronavirus (COVID-19) Update: October 26, 2021
Read more: Coronavirus (COVID-19) Update: October 26, 2021
Pharma Reviews: NPPA caps ceiling prices of 12 anti-diabetic generic medicines towards ... - The Financial Express
To make diabetic treatment affordable, National Pharmaceutical Pricing Authority ... know market's Top Gainers, Top Losers & Best Equity Funds.
Read more: NPPA caps ceiling prices of 12 anti-diabetic generic medicines towards ... - The Financial Express
Read more: NPPA caps ceiling prices of 12 anti-diabetic generic medicines towards ... - The Financial Express
Pharma Reviews: JSW Steel to spend ₹28,000 crore for expansion - Fortune India
In addition, there is huge demand for Indian steel in export markets which China has ... Quality issues remain for Indian pharma companies: USFDA ...
Read more: JSW Steel to spend ₹28,000 crore for expansion - Fortune India
Read more: JSW Steel to spend ₹28,000 crore for expansion - Fortune India
Pharma Reviews: Torrent Pharma shares up 0.39% as Nifty gains - The Economic Times
Torrent Pharmaceuticals Ltd. belongs to the Pharma - Indian industry. ... (What's moving Sensex and Nifty Track latest market news, stock tips and ...
Read more: Torrent Pharma shares up 0.39% as Nifty gains - The Economic Times
Read more: Torrent Pharma shares up 0.39% as Nifty gains - The Economic Times
Monday, October 25, 2021
Pharma Reviews: What is PM Ayushman Bharat Health Infrastructure Mission (PMABHIM)? - Fortune India
First proposed during the 2021-2022 union budget, the PMABHIM entails a slew of infrastructure development schemes in the healthcare sector.
Read more: What is PM Ayushman Bharat Health Infrastructure Mission (PMABHIM)? - Fortune India
Read more: What is PM Ayushman Bharat Health Infrastructure Mission (PMABHIM)? - Fortune India
Pharma Reviews: Dr. Mansukh Mandaviya to address the Investor Summit – “Opportunities and Partnerships ...
New Delhi : As part of the vision to further strengthen India's ... Indian pharma market is expected to grow to US$ 130 billion by 2030: DV ...
Read more: Dr. Mansukh Mandaviya to address the Investor Summit – “Opportunities and Partnerships ...
Read more: Dr. Mansukh Mandaviya to address the Investor Summit – “Opportunities and Partnerships ...
Pharma Reviews: Institutional investors favour 13 resolutions, dissent against one since Oct 16 - The Financial Express
The pharma company's resolution to appoint Rajender Juvvadi Rao as ... proxy advisory firm Institutional Investor Advisory Services India (IiAS), ...
Read more: Institutional investors favour 13 resolutions, dissent against one since Oct 16 - The Financial Express
Read more: Institutional investors favour 13 resolutions, dissent against one since Oct 16 - The Financial Express
Pharma Reviews: Stock market update: Nifty Pharma index falls 0.04% - The Economic Times
The Nifty Pharma index closed 0.04 per cent down at 13943.85. ... Divis Laboratories(down 1.53 per cent) and Granules India(down 1.5 per cent) ...
Read more: Stock market update: Nifty Pharma index falls 0.04% - The Economic Times
Read more: Stock market update: Nifty Pharma index falls 0.04% - The Economic Times
Pharma Reviews: The Value Of Best Apollo Pharmaceutical [Learn How To Begin] - Inventiva
India is the largest exporter of medication on the international market. With over 3500 locations, Apollo Pharmacy has been one of the leading ...
Read more: The Value Of Best Apollo Pharmaceutical [Learn How To Begin] - Inventiva
Read more: The Value Of Best Apollo Pharmaceutical [Learn How To Begin] - Inventiva
Pharma Reviews: Diwali gifts are not tax-free; here's what will be taxed - Fortune India
Instead of gifts, some companies pay Diwali bonus. This is considered a part of salary. The bonus is added to the income and taxed.
Read more: Diwali gifts are not tax-free; here's what will be taxed - Fortune India
Read more: Diwali gifts are not tax-free; here's what will be taxed - Fortune India
Pharma Reviews: The Indian healthcare industry will continue to draw investor attention - Hindustan Times
A sizable portion of the investment will be directed towards hospitals & health centres, pharma companies, and medical equipment manufacturing.
Read more: The Indian healthcare industry will continue to draw investor attention - Hindustan Times
Read more: The Indian healthcare industry will continue to draw investor attention - Hindustan Times
US FDA News: FDA In Brief: FDA Makes Progress on Efforts to Understand Presence of Asbestos in Cosmetic Products
The FY 2020 - 2021 sampling assignment tested talc-containing cosmetic products for the presence of asbestos, all samples tested negative and there were no positive findings
Read more: FDA In Brief: FDA Makes Progress on Efforts to Understand Presence of Asbestos in Cosmetic Products
Read more: FDA In Brief: FDA Makes Progress on Efforts to Understand Presence of Asbestos in Cosmetic Products
Pharma Reviews: Healthminds Consulting appoints Dr Lt BG Ravindranath Kunjithai as VP of Strategy & Growth
He has also worked with leading Indian and global pharma companies like Indegene, Biocon, Novartis and Sayre Therapeutics and made meaningful ...
Read more: Healthminds Consulting appoints Dr Lt BG Ravindranath Kunjithai as VP of Strategy & Growth
Read more: Healthminds Consulting appoints Dr Lt BG Ravindranath Kunjithai as VP of Strategy & Growth
Pharma Reviews: Modi interacts with domestic vaccine manufacturers - Express Pharma
He also said that the entire world is looking up to India, ... between government and industry, and applauded the regulatory reforms, ...
Read more: Modi interacts with domestic vaccine manufacturers - Express Pharma
Read more: Modi interacts with domestic vaccine manufacturers - Express Pharma
Pharma Reviews: Share Market LIVE: Sensex erases all gains, gives up 61000, Nifty below 18100
Indian markets opened lower following mixed Asian market cues as global ... Nifty Auto, Nifty FMCG, Nifty IT, Nifty Media, and Nifty Pharma were ...
Read more: Share Market LIVE: Sensex erases all gains, gives up 61000, Nifty below 18100
Read more: Share Market LIVE: Sensex erases all gains, gives up 61000, Nifty below 18100
Sunday, October 24, 2021
Pharma Reviews: Kyrsten Sinema takes thousands in campaign contributions from pharmaceutical giants ...
Kyrsten Sinema's campaign has received $500000+ in campaign donations from the pharma industry. The $3.5 trillion spending bill would save the US ...
Read more: Kyrsten Sinema takes thousands in campaign contributions from pharmaceutical giants ...
Read more: Kyrsten Sinema takes thousands in campaign contributions from pharmaceutical giants ...
Pharma Reviews: PM Modi to inaugurate medical colleges, launch health scheme in UP tomorrow ... - ETHealthworld
PMASBY scheme by the government of India will be an addition to the ... by ramping up the pharma manufacturing sector and maintaining a resilient ...
Read more: PM Modi to inaugurate medical colleges, launch health scheme in UP tomorrow ... - ETHealthworld
Read more: PM Modi to inaugurate medical colleges, launch health scheme in UP tomorrow ... - ETHealthworld
Pharma Reviews: USD 100 billion nutraceutical market of India: An opportunity in making - The Financial Express
India has 7000 plants that contribute to medicines/ nutraceuticals and 1200 ... The strength of Indian pharmaceutical formulation and clinical ...
Read more: USD 100 billion nutraceutical market of India: An opportunity in making - The Financial Express
Read more: USD 100 billion nutraceutical market of India: An opportunity in making - The Financial Express
Pharma Reviews: New IPL teams: BCCI expects Rs 7000 crore-10000 crore with Adani, Goenka, Aurobindo in fray
The Indian cricket board will be expecting the two new IPL franchises to go ... companies which are in fray comprise Kotak group, pharmaceutical ...
Read more: New IPL teams: BCCI expects Rs 7000 crore-10000 crore with Adani, Goenka, Aurobindo in fray
Read more: New IPL teams: BCCI expects Rs 7000 crore-10000 crore with Adani, Goenka, Aurobindo in fray
Saturday, October 23, 2021
Pharma Reviews: Speed up: PM Modi to vaccine makers - Deccan Chronicle
The PM also talked about increasing innovation in the pharmaceutical sector to make India a drug and vaccine manufacturing hub. (PTI).
Read more: Speed up: PM Modi to vaccine makers - Deccan Chronicle
Read more: Speed up: PM Modi to vaccine makers - Deccan Chronicle
Pharma Reviews: How Glass Packaging is Ensuring Sustainability and Adaptability towards India's health ...
... from changing consumer attitudes and growing market trends in speciality and premium goods. ... Time for Indian Pharma to Digest “RICE”?
Read more: How Glass Packaging is Ensuring Sustainability and Adaptability towards India's health ...
Read more: How Glass Packaging is Ensuring Sustainability and Adaptability towards India's health ...
Pharma Reviews: Can data overtake oil in RIL? - Fortune India
Oil is still ahead of data in Reliance Industries (RIL), but the gap is narrowing. The earnings before interest, tax, depreciation and ...
Read more: Can data overtake oil in RIL? - Fortune India
Read more: Can data overtake oil in RIL? - Fortune India
Pharma Reviews: Closing Bell: Sensex, Nifty End Lower Amid Volatility; Metal, IT Drag - Moneycontrol
On the sectoral front, IT, metal, pharma, FMCG fell 1-3 percent. ... However, the Indian market is impacted by muted Q2 results, which are weak ...
Read more: Closing Bell: Sensex, Nifty End Lower Amid Volatility; Metal, IT Drag - Moneycontrol
Read more: Closing Bell: Sensex, Nifty End Lower Amid Volatility; Metal, IT Drag - Moneycontrol
Pharma Reviews: Funding Alert: MEDdelivery Announced A New Funding Round-2021 - Inventiva
The Indian pharmaceutical industry is also seeing a big change with the introduction of technology in it. The top 5 AI companies in India that are ...
Read more: Funding Alert: MEDdelivery Announced A New Funding Round-2021 - Inventiva
Read more: Funding Alert: MEDdelivery Announced A New Funding Round-2021 - Inventiva
Pharma Reviews: Modi addresses India on achieving milestone of 100 crore vaccinations - Express Pharma
Indian pharma companies cater to over half of the global demand for various vaccines, along with 40 per cent of generic drugs demand in the US.
Read more: Modi addresses India on achieving milestone of 100 crore vaccinations - Express Pharma
Read more: Modi addresses India on achieving milestone of 100 crore vaccinations - Express Pharma
Friday, October 22, 2021
Pharma Reviews: Pb seeks pharma park at Bathinda - Millennium Post
The pharma industry will also receive substantial support from some of the largest USFDA-approved pharmaceutical companies, such as Sun Pharma, ...
Read more: Pb seeks pharma park at Bathinda - Millennium Post
Read more: Pb seeks pharma park at Bathinda - Millennium Post
US FDA News: Coronavirus (COVID-19) Update: October 22, 2021
Coronavirus (COVID-19) Update: October 22, 2021
Read more: Coronavirus (COVID-19) Update: October 22, 2021
Read more: Coronavirus (COVID-19) Update: October 22, 2021
Pharma Reviews: Punjab finance minister meets Mandaviya, seeks establishment of pharma park in Bathinda ...
The pharmaceutical industry would also receive substantial support from some ... besides All Indian Institute of Medical Sciences and Institute of ...
Read more: Punjab finance minister meets Mandaviya, seeks establishment of pharma park in Bathinda ...
Read more: Punjab finance minister meets Mandaviya, seeks establishment of pharma park in Bathinda ...
Pharma Reviews: Stock market update: Nifty Pharma index falls 1.55% - The Economic Times
Shares of YES Bank, Rail Vikas Nigam, Federal Bank, Indian Railway Finance Corporation Ltd. and PNB were among the most traded shares on the NSE.
Read more: Stock market update: Nifty Pharma index falls 1.55% - The Economic Times
Read more: Stock market update: Nifty Pharma index falls 1.55% - The Economic Times
Pharma Reviews: PCIM&H, AHP to help develop confidence of global community about safety of Ayush drugs
Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) and ... for the market authorization of Ayush products/drugs in the US.
Read more: PCIM&H, AHP to help develop confidence of global community about safety of Ayush drugs
Read more: PCIM&H, AHP to help develop confidence of global community about safety of Ayush drugs
Pharma Reviews: Serum Institute sees 'large' Covid-19 vaccine exports as output nearly quadruples
New Delhi: The Serum Institute of India (SII), the world's biggest vaccine ... Indian Pharma Market sees 13 percent growth in September sales: ...
Read more: Serum Institute sees 'large' Covid-19 vaccine exports as output nearly quadruples
Read more: Serum Institute sees 'large' Covid-19 vaccine exports as output nearly quadruples
Pharma Reviews: With 100 crore COVID vaccine doses mark, India's role as pharmacy of world becomes more ...
... India emerged out of its effects by ramping up the pharma manufacturing sector and maintaining a resilient supply chain of essential drugs.
Read more: With 100 crore COVID vaccine doses mark, India's role as pharmacy of world becomes more ...
Read more: With 100 crore COVID vaccine doses mark, India's role as pharmacy of world becomes more ...
Pharma Reviews: After a robust rally, pharma stocks feel under the weather. But do they make a case for value buy?
When Covid-19 rattled the stock market in March 2020, the pharma index not only cushioned the fall for investors but ended up delivering lucrative ...
Read more: After a robust rally, pharma stocks feel under the weather. But do they make a case for value buy?
Read more: After a robust rally, pharma stocks feel under the weather. But do they make a case for value buy?
Pharma Reviews: Adar Poonawalla says Serum might export 20-30 million vaccine doses a month to COVAX ...
Express Pharma, first published as Express Pharma Pulse in 1994, is today India's leading business fortnightly for the pharmaceutical industry. With ...
Read more: Adar Poonawalla says Serum might export 20-30 million vaccine doses a month to COVAX ...
Read more: Adar Poonawalla says Serum might export 20-30 million vaccine doses a month to COVAX ...
Pharma Reviews: Pharma Q2 Earnings Preview - Recovery In India Trends To Drive Growth, Offset U.S. ...
Indian Pharma Market is expected to grow largely from non-Covid-19 products' (chronic/sub chronic and acute therapy products') sales, ...
Read more: Pharma Q2 Earnings Preview - Recovery In India Trends To Drive Growth, Offset U.S. ...
Read more: Pharma Q2 Earnings Preview - Recovery In India Trends To Drive Growth, Offset U.S. ...
Wednesday, October 20, 2021
US FDA News: FDA In Brief: FDA Announces Investigation of Salmonella Outbreak Linked to Whole, Fresh Onions
The FDA, along with the CDC and our state and local partners, are working to investigate a multistate outbreak of Salmonella Oranienburg infections linked to linked to whole, fresh onions
Read more: FDA In Brief: FDA Announces Investigation of Salmonella Outbreak Linked to Whole, Fresh Onions
Read more: FDA In Brief: FDA Announces Investigation of Salmonella Outbreak Linked to Whole, Fresh Onions
US FDA News: Coronavirus (COVID-19) Update: FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines
The FDA took additional actions regarding booster doses of COVID-19 vaccines, including authorizing heterologous (or “mix and match”) booster doses in eligible individuals following completion of primary vaccination with a different available COVID-19 vaccine.
Read more: Coronavirus (COVID-19) Update: FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines
Read more: Coronavirus (COVID-19) Update: FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines
US FDA News: Merck Issues Voluntary Nationwide Recall of CUBICIN® (Daptomycin for Injection) 500 mg, Lot 934778, Due to Presence of Particulate Matter Identified as Glass Particles
Merck (NYSE: MRK), known as MSD outside the United States and Canada, is voluntarily recalling one lot of CUBICIN® (daptomycin for injection) 500mg for intravenous use, Lot 934778, Exp June 2022. Because treatment with CUBICIN is likely to be initiated at a hospital or other monitored healthcare se
Read more: Merck Issues Voluntary Nationwide Recall of CUBICIN® (Daptomycin for Injection) 500 mg, Lot 934778, Due to Presence of Particulate Matter Identified as Glass Particles
Read more: Merck Issues Voluntary Nationwide Recall of CUBICIN® (Daptomycin for Injection) 500 mg, Lot 934778, Due to Presence of Particulate Matter Identified as Glass Particles
US FDA News: Federal judge enters consent decree with Utah-based dietary supplement manufacturer
A dietary supplement manufacturer has been ordered to stop selling products until they come into compliance under the Federal Food, Drug, and Cosmetic Act
Read more: Federal judge enters consent decree with Utah-based dietary supplement manufacturer
Read more: Federal judge enters consent decree with Utah-based dietary supplement manufacturer
Tuesday, October 19, 2021
US FDA News: Coronavirus (COVID-19) Update: October 19, 2021
Coronavirus (COVID-19) Update: October 19, 2021
Read more: Coronavirus (COVID-19) Update: October 19, 2021
Read more: Coronavirus (COVID-19) Update: October 19, 2021
US FDA News: Bryant Ranch Prepack Issues Voluntary Nationwide Recall of Methocarbamol 500mg Bottles Due to Mislabeling With the Incorrect Strength
Burbank, CA, Bryant Ranch Prepack is voluntarily recalling 1 lot of Methocarbamol 500mg, Tablets to the consumer level. The bottles labeled as Methocarbamol 500mg Tablets have been found to contain Methocarbamol 750mg Tablets. If a patient takes a 750mg Tablet of Methocarbamol instead of the prescri
Read more: Bryant Ranch Prepack Issues Voluntary Nationwide Recall of Methocarbamol 500mg Bottles Due to Mislabeling With the Incorrect Strength
Read more: Bryant Ranch Prepack Issues Voluntary Nationwide Recall of Methocarbamol 500mg Bottles Due to Mislabeling With the Incorrect Strength
US FDA News: Cook Medical Issues Voluntary Recall of Transseptal Needle and Transseptal Needle with Catheter
Cook Medical issued a global, voluntary recall of the Transseptal Needle and the Transseptal Needle with Catheter. This recall includes all unexpired lots for both of these products. The needles were recalled due to complaints of rust on the products.
Read more: Cook Medical Issues Voluntary Recall of Transseptal Needle and Transseptal Needle with Catheter
Read more: Cook Medical Issues Voluntary Recall of Transseptal Needle and Transseptal Needle with Catheter
US FDA News: FDA Permits Marketing of New Oral Tobacco Products through Premarket Tobacco Product Application Pathway
FDA authorized the marketing of four new Verve oral tobacco products manufactured by U.S. Smokeless Tobacco Company LLC.
Read more: FDA Permits Marketing of New Oral Tobacco Products through Premarket Tobacco Product Application Pathway
Read more: FDA Permits Marketing of New Oral Tobacco Products through Premarket Tobacco Product Application Pathway
US FDA News: FDA Issues Landmark Proposal to Improve Access to Hearing Aid Technology for Millions of Americans
FDA issued a proposed rule to establish a new category of over-the-counter hearing aids. When finalized, the rule would allow hearing aids that fall within this category to be sold directly to consumers in stores or online without a medical exam or a fitting by an audiologist.
Read more: FDA Issues Landmark Proposal to Improve Access to Hearing Aid Technology for Millions of Americans
Read more: FDA Issues Landmark Proposal to Improve Access to Hearing Aid Technology for Millions of Americans
Monday, October 18, 2021
US FDA News: FDA Approves Cyltezo, the First Interchangeable Biosimilar to Humira
The U.S. Food and Drug Administration today approved the first interchangeable biosimilar product to treat certain inflammatory diseases. Cyltezo (adalimumab-adbm) is now approved as interchangeable with (and may be substituted for) its reference product Humira (adalimumab).
Read more: FDA Approves Cyltezo, the First Interchangeable Biosimilar to Humira
Read more: FDA Approves Cyltezo, the First Interchangeable Biosimilar to Humira
Friday, October 15, 2021
Thursday, October 14, 2021
US FDA News: Abbott Molecular, Inc. Recalls Alinity m SARS-CoV-2 AMP Kit and Alinity m Resp-4-Plex AMP Kit for Potential False Positive SARS-CoV-2 Test Results
Abbott is recalling Alinity m SARS-CoV-2 and Alinity m Resp-4-Plex AMP Kits because they may cause false positive SARS-CoV-2 results
Read more: Abbott Molecular, Inc. Recalls Alinity m SARS-CoV-2 AMP Kit and Alinity m Resp-4-Plex AMP Kit for Potential False Positive SARS-CoV-2 Test Results
Read more: Abbott Molecular, Inc. Recalls Alinity m SARS-CoV-2 AMP Kit and Alinity m Resp-4-Plex AMP Kit for Potential False Positive SARS-CoV-2 Test Results
US FDA News: FDA to Hold Advisory Committee Meeting to Discuss Merck and Ridgeback’s EUA Application for COVID-19 Oral Treatment
The FDA is announcing an upcoming meeting of its Antimicrobial Drugs Advisory Committee (AMDAC) to discuss Merck and Ridgeback’s Application for the Emergency Use of a COVID-19 Oral Treatment
Read more: FDA to Hold Advisory Committee Meeting to Discuss Merck and Ridgeback’s EUA Application for COVID-19 Oral Treatment
Read more: FDA to Hold Advisory Committee Meeting to Discuss Merck and Ridgeback’s EUA Application for COVID-19 Oral Treatment
US FDA News: FDA Awards 11 Grants to Clinical Trials to Develop New Medical Products for Rare Disease Treatments
Today, the U.S. Food and Drug Administration announced it has awarded 11 new clinical trial research grants, equaling more than $25 million of funding over the next four years.
Read more: FDA Awards 11 Grants to Clinical Trials to Develop New Medical Products for Rare Disease Treatments
Read more: FDA Awards 11 Grants to Clinical Trials to Develop New Medical Products for Rare Disease Treatments
US FDA News: Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of All Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets Due to Potential Presence of N-nitrosoirbesartan Impurity
Baltimore, Maryland, October 14, 2021: Lupin Pharmaceuticals Inc. is voluntarily recalling the below-mentioned batches of Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets to the consumer level. As part of Lupin’s ongoing assessment, analysis revealed that certain tested API batches
Read more: Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of All Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets Due to Potential Presence of N-nitrosoirbesartan Impurity
Read more: Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of All Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets Due to Potential Presence of N-nitrosoirbesartan Impurity
Wednesday, October 13, 2021
US FDA News: UPDATE: Potential Risk of Infection When Using Heater-Cooler Devices – Letter to Health Care Providers
The FDA provides updated information from our ongoing evaluation of NTM infections in patients who have had cardiothoracic surgery using heater-cooler devices.
Read more: UPDATE: Potential Risk of Infection When Using Heater-Cooler Devices – Letter to Health Care Providers
Read more: UPDATE: Potential Risk of Infection When Using Heater-Cooler Devices – Letter to Health Care Providers
US FDA News: To Improve Nutrition and Reduce the Burden of Disease, FDA Issues Food Industry Guidance for Voluntarily Reducing Sodium in Processed and Packaged Foods
FDA Issues Final Guidance to Food Industry for Voluntarily Reducing Sodium in Processed and Packaged Foods
Read more: To Improve Nutrition and Reduce the Burden of Disease, FDA Issues Food Industry Guidance for Voluntarily Reducing Sodium in Processed and Packaged Foods
Read more: To Improve Nutrition and Reduce the Burden of Disease, FDA Issues Food Industry Guidance for Voluntarily Reducing Sodium in Processed and Packaged Foods
Tuesday, October 12, 2021
US FDA News: Teligent Pharma, Inc.’s Issues Worldwide Voluntary Recall of Lidocaine HCl Topical Solution 4% Due to Super Potency
Buena, NJ, Teligent Pharma, Inc. is voluntarily recalling the five lots of Lidocaine HCl Topical Solution 4%, 50ml in a screw cap glass bottle listed in the table below to the user level. The product is being recalled because the firms testing has found it to be super potent based on an Out of Speci
Read more: Teligent Pharma, Inc.’s Issues Worldwide Voluntary Recall of Lidocaine HCl Topical Solution 4% Due to Super Potency
Read more: Teligent Pharma, Inc.’s Issues Worldwide Voluntary Recall of Lidocaine HCl Topical Solution 4% Due to Super Potency
US FDA News: Coronavirus (COVID-19) Update: October 12, 2021
Coronavirus (COVID-19) Update: October 12, 2021
Read more: Coronavirus (COVID-19) Update: October 12, 2021
Read more: Coronavirus (COVID-19) Update: October 12, 2021
US FDA News: FDA Permits Marketing of E-Cigarette Products, Marking First Authorization of Its Kind by the Agency
FDA authorized the marketing of three new tobacco products, marking the first set of electronic nicotine delivery system (ENDS) products ever to be authorized by the agency through the Premarket Tobacco Product Application (PMTA) pathway.
Read more: FDA Permits Marketing of E-Cigarette Products, Marking First Authorization of Its Kind by the Agency
Read more: FDA Permits Marketing of E-Cigarette Products, Marking First Authorization of Its Kind by the Agency
US FDA News: Potential for Medication Overdose with ENFit Low Dose Tip Syringe: FDA Safety Communication
How to optimize dose accuracy when using ENFit LDT syringes – recommendations for patients and health care providers
Read more: Potential for Medication Overdose with ENFit Low Dose Tip Syringe: FDA Safety Communication
Read more: Potential for Medication Overdose with ENFit Low Dose Tip Syringe: FDA Safety Communication
US FDA News: FDA In Brief: FDA Withdrawing Temporary Guidances for Alcohol-Based Hand Sanitizers
The FDA is withdrawing the temporary policies outlined in the guidances for the preparation of certain alcohol-based hand sanitizer products and alcohol for use in hand sanitizers
Read more: FDA In Brief: FDA Withdrawing Temporary Guidances for Alcohol-Based Hand Sanitizers
Read more: FDA In Brief: FDA Withdrawing Temporary Guidances for Alcohol-Based Hand Sanitizers
Monday, October 11, 2021
Pharma Reviews: Indian govt's reform measures 'powerful message' for western investors: ATC Exec VP ...
The measures undertaken by the Indian government on reforms has sent a “very ... “Singh opined that India's healthcare industry is ripe for investment.
Read more: Indian govt's reform measures 'powerful message' for western investors: ATC Exec VP ...
Read more: Indian govt's reform measures 'powerful message' for western investors: ATC Exec VP ...
Pharma Reviews: India currently contributes three-to-five per cent share of the global biotechnology sector ...
However, a majority of Indian biotech and pharmaceutical businesses are still focussing on the generic drug market and are not necessarily involved in New ...
Read more: India currently contributes three-to-five per cent share of the global biotechnology sector ...
Read more: India currently contributes three-to-five per cent share of the global biotechnology sector ...
Pharma Reviews: India allows export of Hetero Biopharma produced Sputnik Light - Medical Dialogues
Over the past months, the RDIF has been working closely with Indian pharmaceutical companies to ramp up the production of Sputnik vaccine in India that could be ...
Read more: India allows export of Hetero Biopharma produced Sputnik Light - Medical Dialogues
Read more: India allows export of Hetero Biopharma produced Sputnik Light - Medical Dialogues
Sunday, October 10, 2021
Pharma Reviews: Here Are Six Sectors That Mutual Funds Like The Most - Moneycontrol
Between 2015 and 2020 Indian pharma companies had a rough ride. However, rising demand for certain drugs during the Covid-19 pandemic pushed pharma stocks ...
Read more: Here Are Six Sectors That Mutual Funds Like The Most - Moneycontrol
Read more: Here Are Six Sectors That Mutual Funds Like The Most - Moneycontrol
Saturday, October 9, 2021
Pharma Reviews: Infallible Pharma eyes to boost presence in critical care segment in India, overseas
New Delhi: Infallible Pharma, a certified pharmaceutical company of Indian origin, has achieved number one position in anticoagulant segment in India by ...
Read more: Infallible Pharma eyes to boost presence in critical care segment in India, overseas
Read more: Infallible Pharma eyes to boost presence in critical care segment in India, overseas
Pharma Reviews: Aurobindo Pharma, MSN seek CDSCO panel nod to cease Molnupiravir trial on moderate ...
... Co's experimental antiviral drug Molnupiravir in moderate Covid-19 patients, two Indian pharmaceutical companies, Aurobindo Pharma and MSN Laboratories, ...
Read more: Aurobindo Pharma, MSN seek CDSCO panel nod to cease Molnupiravir trial on moderate ...
Read more: Aurobindo Pharma, MSN seek CDSCO panel nod to cease Molnupiravir trial on moderate ...
Friday, October 8, 2021
Pharma Reviews: Aurobindo Pharma, MSN Labs seek DGCI nod for Phase-III trials of Merck's molnupiravir ...
ET has seen the minutes of the SEC meeting. Reuters. Two Indian pharmaceutical companies have sought permission from India's drug regulator to continue phase ...
Read more: Aurobindo Pharma, MSN Labs seek DGCI nod for Phase-III trials of Merck's molnupiravir ...
Read more: Aurobindo Pharma, MSN Labs seek DGCI nod for Phase-III trials of Merck's molnupiravir ...
US FDA News: FDA Approves Innovative Treatment for Pediatric Patients with Congenital Athymia
FDA approves Rethymic for immune reconstitution in pediatric patients with congenital athymia which is the first thymus tissue product approved in the U.S.
Read more: FDA Approves Innovative Treatment for Pediatric Patients with Congenital Athymia
Read more: FDA Approves Innovative Treatment for Pediatric Patients with Congenital Athymia
US FDA News: FDA In Brief: FDA Warns Public and Health Care Professionals Not to Use Needle-free Devices for Injection of Dermal Fillers
FDA is warning the public and health care professionals not to use needle-free devices commonly referred to as dermal fillers or fillers.
Read more: FDA In Brief: FDA Warns Public and Health Care Professionals Not to Use Needle-free Devices for Injection of Dermal Fillers
Read more: FDA In Brief: FDA Warns Public and Health Care Professionals Not to Use Needle-free Devices for Injection of Dermal Fillers
US FDA News: Do Not Use Needle-Free Devices for Injection of Dermal Fillers – FDA Safety Communication
The FDA warns public and health care providers not to use needle-free devices for injection of dermal fillers.
Read more: Do Not Use Needle-Free Devices for Injection of Dermal Fillers – FDA Safety Communication
Read more: Do Not Use Needle-Free Devices for Injection of Dermal Fillers – FDA Safety Communication
Pharma Reviews: Two Indian drugmakers seek to end trials of Merck's antiviral drug for moderate COVID-19
Of the eight Indian firms, five - Dr Reddy's Laboratories, Cipla, Sun Pharma, Torrent Pharmaceuticals and Emcure Pharmaceuticals - are conducting a joint ...
Read more: Two Indian drugmakers seek to end trials of Merck's antiviral drug for moderate COVID-19
Read more: Two Indian drugmakers seek to end trials of Merck's antiviral drug for moderate COVID-19
Thursday, October 7, 2021
Pharma Reviews: Indian pharma requires a fresh approach, strategic investments and outcome-specific thinking
Collaboration and quick action were the need of the hour. And that was exactly what the Indian pharmaceutical sector did to ensure that every possible solution ...
Read more: Indian pharma requires a fresh approach, strategic investments and outcome-specific thinking
Read more: Indian pharma requires a fresh approach, strategic investments and outcome-specific thinking
US FDA News: FDA Issues Final Order and Guidance on Surgical Staplers and Staples for Internal Use
FDA issues final order reclassifying surgical staplers for internal use requiring them to undergo premarket review, final guidance for labeling requirements for patient risk communication and a letter to health care providers to increase their safe use.
Read more: FDA Issues Final Order and Guidance on Surgical Staplers and Staples for Internal Use
Read more: FDA Issues Final Order and Guidance on Surgical Staplers and Staples for Internal Use
US FDA News: FDA Announces Signing of Domestic Mutual Reliance Agreements with California, Florida, Utah and Wisconsin
The FDA announced that California, Florida, Utah and Wisconsin have entered into domestic mutual reliance agreements with the agency
Read more: FDA Announces Signing of Domestic Mutual Reliance Agreements with California, Florida, Utah and Wisconsin
Read more: FDA Announces Signing of Domestic Mutual Reliance Agreements with California, Florida, Utah and Wisconsin
US FDA News: UPDATE: Safe Use of Surgical Staplers and Staples - Letter to Health Care Providers
The FDA is providing updated recommendations to help protect patient safety and reduce the risk of adverse events associated with surgical staplers.
Read more: UPDATE: Safe Use of Surgical Staplers and Staples - Letter to Health Care Providers
Read more: UPDATE: Safe Use of Surgical Staplers and Staples - Letter to Health Care Providers
Pharma Reviews: Covid-19 thrusting the pharma industry to expand - The Financial Express
Prime Minister Narendra Modi said India can help in bringing the world out of the coronavirus crisis with mass vaccine distribution once all trials are ...
Read more: Covid-19 thrusting the pharma industry to expand - The Financial Express
Read more: Covid-19 thrusting the pharma industry to expand - The Financial Express
Pharma Reviews: West Pharma launches NovaGuard SA Pro Safety System in India
West Pharmaceutical Services has launched NovaGuard SA Pro Safety System, a single-use accessory for prefilled ISO standard 0.5mL staked needle syringes, In ...
Read more: West Pharma launches NovaGuard SA Pro Safety System in India
Read more: West Pharma launches NovaGuard SA Pro Safety System in India
Pharma Reviews: West Expands its NovaGuard® SA Pro Safety System Offerings in India with the Launch of ...
West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug and healthcare products, recently announced its ...
Read more: West Expands its NovaGuard® SA Pro Safety System Offerings in India with the Launch of ...
Read more: West Expands its NovaGuard® SA Pro Safety System Offerings in India with the Launch of ...
US FDA News: FDA In Brief: FDA Warns Firms for Continuing to Market E-cigarette Products After Agency Denied Authorizations
FDA issued warning letters to 20 companies for continuing to unlawfully market e-cigarette products with Marketing Denial Orders.
Read more: FDA In Brief: FDA Warns Firms for Continuing to Market E-cigarette Products After Agency Denied Authorizations
Read more: FDA In Brief: FDA Warns Firms for Continuing to Market E-cigarette Products After Agency Denied Authorizations
Pharma Reviews: Avoiding pitfalls in life science transactions - The Financial Express
Collaborative partnerships are of increasing importance for successful innovation in the life science industry. Updated: Oct 07, 2021 1:25 PM. collaborative ...
Read more: Avoiding pitfalls in life science transactions - The Financial Express
Read more: Avoiding pitfalls in life science transactions - The Financial Express
Pharma Reviews: West expands its NovaGuard SA Pro Safety System offerings in India with launch of 0.5mL
West Pharmaceutical Services, a global leader in innovative solutions for injectable drug and healthcare products, recently announced its latest offering for ...
Read more: West expands its NovaGuard SA Pro Safety System offerings in India with launch of 0.5mL
Read more: West expands its NovaGuard SA Pro Safety System offerings in India with launch of 0.5mL
Pharma Reviews: Beauty & Personal Care and Health & Pharma Segment Registering Maximum E-Commerce ...
The pandemic caused by Covid-19 has led to growth in e-commerce sector across categories like beauty and personal care, health and pharma, FMCG, nutraceutical, ...
Read more: Beauty & Personal Care and Health & Pharma Segment Registering Maximum E-Commerce ...
Read more: Beauty & Personal Care and Health & Pharma Segment Registering Maximum E-Commerce ...
Wednesday, October 6, 2021
Pharma Reviews: Gujarat pharma showcased at Dubai Expo | Ahmedabad News - Times of India
Ahmedabad: Growth opportunities in Gujarat's pharmaceutical sector were showcased on Tuesday at the ongoing Expo 2020 Dubai. Led by Gujarat Pollution ...
Read more: Gujarat pharma showcased at Dubai Expo | Ahmedabad News - Times of India
Read more: Gujarat pharma showcased at Dubai Expo | Ahmedabad News - Times of India
Pharma Reviews: West expands its NovaGuard® SA Pro Safety System offerings in - ANI News
ANI | Updated: Oct 06, 2021 18:14 IST. Hyderabad (Telangana) [India], October 6 (ANI/NewsVoir): West Pharmaceutical Services, Inc. (West), a global leader ...
Read more: West expands its NovaGuard® SA Pro Safety System offerings in - ANI News
Read more: West expands its NovaGuard® SA Pro Safety System offerings in - ANI News
Pharma Reviews: SA Pro Safety System offerings in India with launch of 0.5mL Standard Syringe Device - ANI News
Hyderabad (Telangana) [India], October 6 (ANI/NewsVoir): West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug ...
Read more: SA Pro Safety System offerings in India with launch of 0.5mL Standard Syringe Device - ANI News
Read more: SA Pro Safety System offerings in India with launch of 0.5mL Standard Syringe Device - ANI News
US FDA News: Imperative Care Inc. Recalls ZOOM 71 Reperfusion Catheter Due to Risk of Breaks During Use
Imperative Care is recalling ZOOM 71 Reperfusion Catheter, used to remove blood clots in the brain, due to risk of breaking during use.
Read more: Imperative Care Inc. Recalls ZOOM 71 Reperfusion Catheter Due to Risk of Breaks During Use
Read more: Imperative Care Inc. Recalls ZOOM 71 Reperfusion Catheter Due to Risk of Breaks During Use
US FDA News: FDA Revises Hospital and Health System Compounding Guidance to Help Preserve Patient Access to Compounded Drugs
FDA is revising its Hospital and Health System Compounding Guidance to Help Preserve Patient Access to Compounded Drugs
Read more: FDA Revises Hospital and Health System Compounding Guidance to Help Preserve Patient Access to Compounded Drugs
Read more: FDA Revises Hospital and Health System Compounding Guidance to Help Preserve Patient Access to Compounded Drugs
US FDA News: DeRoyal Industries, Inc. Recalls Procedure Packs Containing Smiths Medical NORMOFLO Irrigation Warming Set Due to the Possibility of Harmful Levels of Aluminum Leaching into the Fluid Path of the Warmers
DeRoyal Industries Recalls Procedure Packs Containing NORMOFLO Irrigation Warming Set Due to the Possibility of Harmful Levels of Aluminum Leaching
Read more: DeRoyal Industries, Inc. Recalls Procedure Packs Containing Smiths Medical NORMOFLO Irrigation Warming Set Due to the Possibility of Harmful Levels of Aluminum Leaching into the Fluid Path of the Warmers
Read more: DeRoyal Industries, Inc. Recalls Procedure Packs Containing Smiths Medical NORMOFLO Irrigation Warming Set Due to the Possibility of Harmful Levels of Aluminum Leaching into the Fluid Path of the Warmers
Pharma Reviews: Mankind Pharma ropes in Vijay Sethupathi as brand ambassador | Indian Television Dot Com
FEFSI is an Indian organisation consisting of technicians from the Tamil Film Industry in Tamil Nadu, India. The amount donated will help all those who are ...
Read more: Mankind Pharma ropes in Vijay Sethupathi as brand ambassador | Indian Television Dot Com
Read more: Mankind Pharma ropes in Vijay Sethupathi as brand ambassador | Indian Television Dot Com
Pharma Reviews: More large pharma companies in India are looking to outsource product development and ...
The outsourcing market size for pharmaceutical manufacturing and development in India roughly stands at 20,000 crores and is expected to grow about 40,000 ...
Read more: More large pharma companies in India are looking to outsource product development and ...
Read more: More large pharma companies in India are looking to outsource product development and ...
Pharma Reviews: CLOSING BELL: Sensex ends 555 points lower on weak global cues - The Economic Times
The Department for Promotion of Industry and Internal Trade (DPIIT), on Wednesday, ... News of Cadila Healthcare receiving permission from the Indian drug ...
Read more: CLOSING BELL: Sensex ends 555 points lower on weak global cues - The Economic Times
Read more: CLOSING BELL: Sensex ends 555 points lower on weak global cues - The Economic Times
Tuesday, October 5, 2021
US FDA News: Coronavirus (COVID-19) Update: October 5, 2021
Coronavirus (COVID-19) Update: October 5, 2021
Read more: Coronavirus (COVID-19) Update: October 5, 2021
Read more: Coronavirus (COVID-19) Update: October 5, 2021
US FDA News: Medtronic Recalls Remote Controllers Used with Paradigm and 508 MiniMed Insulin Pumps for Potential Cybersecurity Risks
Medtronic recalled all remote controllers used with the MiniMed 508 and Paradigm family of insulin pumps due to potential cybersecurity risks.
Read more: Medtronic Recalls Remote Controllers Used with Paradigm and 508 MiniMed Insulin Pumps for Potential Cybersecurity Risks
Read more: Medtronic Recalls Remote Controllers Used with Paradigm and 508 MiniMed Insulin Pumps for Potential Cybersecurity Risks
US FDA News: Potential for False Positive Results with Certain Lots of Ellume COVID-19 Home Tests Due to a Manufacturing Issue: FDA Safety Communication
Potential for False Positive Results with Certain Lots of Ellume COVID-19 Home Tests Due to a Manufacturing Issue: FDA Safety Communication
Read more: Potential for False Positive Results with Certain Lots of Ellume COVID-19 Home Tests Due to a Manufacturing Issue: FDA Safety Communication
Read more: Potential for False Positive Results with Certain Lots of Ellume COVID-19 Home Tests Due to a Manufacturing Issue: FDA Safety Communication
Pharma Reviews: pharma: Specialty focused tech businesses to see strong traction, Health News, ET HealthWorld
Within the Indian healthtech sector, specialty focus tech companies will have a ... Closer home in India, pharma companies stand to benefit additionally in ...
Read more: pharma: Specialty focused tech businesses to see strong traction, Health News, ET HealthWorld
Read more: pharma: Specialty focused tech businesses to see strong traction, Health News, ET HealthWorld
Pharma Reviews: Cadila Healthcare gets DCGI nod to conduct phase III trials for two-dose Covid vaccine ...
The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three ...
Read more: Cadila Healthcare gets DCGI nod to conduct phase III trials for two-dose Covid vaccine ...
Read more: Cadila Healthcare gets DCGI nod to conduct phase III trials for two-dose Covid vaccine ...
Pharma Reviews: Uniza Healthcare launches Vitellus for Vitiligo management in India - Medical Dialogues
Ahmedabad: Ahmedabad-based young pharma company, Uniza Healthcare has launched a novel treatment for the management of Vitiligo in Indian Market.
Read more: Uniza Healthcare launches Vitellus for Vitiligo management in India - Medical Dialogues
Read more: Uniza Healthcare launches Vitellus for Vitiligo management in India - Medical Dialogues
US FDA News: Medtronic Recalls MiniMed Insulin Pumps for Incorrect Insulin Dosing
Missing or broken retainer ring could cause under or over delivery of insulin. This may cause patient injury or death.
Read more: Medtronic Recalls MiniMed Insulin Pumps for Incorrect Insulin Dosing
Read more: Medtronic Recalls MiniMed Insulin Pumps for Incorrect Insulin Dosing
Pharma Reviews: IPA appoints Samir Mehta from Torrent, Samina Hamied from Cipla as new office bearers
New Delhi: Indian Pharmaceutical Alliance (IPA) has recently announced the ... "COVID 19 has been a challenging time for the Indian pharmaceutical industry.
Read more: IPA appoints Samir Mehta from Torrent, Samina Hamied from Cipla as new office bearers
Read more: IPA appoints Samir Mehta from Torrent, Samina Hamied from Cipla as new office bearers
Pharma Reviews: Mankind Pharma ropes in Vijay Sethupathi as its brand ambassador | Business Insider India
As a part of the association, Mankind Pharma will donate Rs 31 lakh to the Film Employees Federation of South India (FEFSI). Pharmaceutical company Mankind ...
Read more: Mankind Pharma ropes in Vijay Sethupathi as its brand ambassador | Business Insider India
Read more: Mankind Pharma ropes in Vijay Sethupathi as its brand ambassador | Business Insider India
Monday, October 4, 2021
Pharma Reviews: IPA announces new office bearers - Express Pharma
The Indian Pharmaceutical Alliance has appointed Samir Mehta, Chairman, ... the Industry Vision 2030 of being the largest producer of medicines in the world ...
Read more: IPA announces new office bearers - Express Pharma
Read more: IPA announces new office bearers - Express Pharma
Pharma Reviews: Molnupiravir: Merck to seek EUA from USFDA; trials on in India - The Financial Express
The company also plans to submit marketing applications to regulatory agencies worldwide. If authorised, Molnupiravir could become the oral drug for ...
Read more: Molnupiravir: Merck to seek EUA from USFDA; trials on in India - The Financial Express
Read more: Molnupiravir: Merck to seek EUA from USFDA; trials on in India - The Financial Express
US FDA News: Coronavirus (COVID-19) Update: FDA Authorizes Additional OTC Home Test to Increase Access to Rapid Testing for Consumers
FDA issued an emergency use authorization (EUA) for the ACON Laboratories Flowflex COVID-19 Home Test, an over-the-counter (OTC) COVID-19 test, which adds to the growing list of tests that can be used at home without a prescription.
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Additional OTC Home Test to Increase Access to Rapid Testing for Consumers
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Additional OTC Home Test to Increase Access to Rapid Testing for Consumers
US FDA News: FDA Finalizes Two Foundational Rules for Companies Seeking to Market New Tobacco Products
Today, the U.S. Food and Drug Administration issued two final rules for the premarket review of new tobacco products.
Read more: FDA Finalizes Two Foundational Rules for Companies Seeking to Market New Tobacco Products
Read more: FDA Finalizes Two Foundational Rules for Companies Seeking to Market New Tobacco Products
Pharma Reviews: Need for real-time data is driving Indian pharma to digitise supply chains - The Financial Express
Digitalisation of the supply chain is the new imperative for the Indian pharma companies. Talk to those in the industry and a range of companies get ...
Read more: Need for real-time data is driving Indian pharma to digitise supply chains - The Financial Express
Read more: Need for real-time data is driving Indian pharma to digitise supply chains - The Financial Express
Pharma Reviews: Indian CRO industry is rich and diverse - Express Pharma
Together, we serve clients globally in pharmaceutical and biopharmaceutical, agro-chemical and industrial chemicals, herbal/nutraceuticals and medical devices ...
Read more: Indian CRO industry is rich and diverse - Express Pharma
Read more: Indian CRO industry is rich and diverse - Express Pharma
Pharma Reviews: AI and ML hold answers for Indian pharma's logistics challenges
There hasn't been a more complex challenge to the pharmaceutical industry in recent times as the COVID-19 pandemic. While concerns like batch losses, ...
Read more: AI and ML hold answers for Indian pharma's logistics challenges
Read more: AI and ML hold answers for Indian pharma's logistics challenges
Pharma Reviews: Indian Pharma companies help Ivory Coast gain freedom from diseases - The Financial Express
The Indian mission in Cote d'Ivoire is organising a series of free medical camps and donations of life saving drugs in general hospitals in different parts of ...
Read more: Indian Pharma companies help Ivory Coast gain freedom from diseases - The Financial Express
Read more: Indian Pharma companies help Ivory Coast gain freedom from diseases - The Financial Express
Pharma Reviews: Divis Labs surges 10%, hits record high in Monday's session; here's why - Business Standard
Merck has also struck licensing agreements with Sun Pharmaceuticals, Cipla, Dr Reddy's Laboratories among others to market the drug in India and +100 LMIC ...
Read more: Divis Labs surges 10%, hits record high in Monday's session; here's why - Business Standard
Read more: Divis Labs surges 10%, hits record high in Monday's session; here's why - Business Standard
Pharma Reviews: Sensex Ends 534 Points Higher, Nifty At 17691 As Market Rebounds After 4 Days Of Losses
"The way pharma stocks have behaved certainly shows that the best time possibly, ... "After a week-long consolidation, the Indian market is back in action ...
Read more: Sensex Ends 534 Points Higher, Nifty At 17691 As Market Rebounds After 4 Days Of Losses
Read more: Sensex Ends 534 Points Higher, Nifty At 17691 As Market Rebounds After 4 Days Of Losses
Sunday, October 3, 2021
Pharma Reviews: Covid-19: Why Indian medical device industry is in dire need to gain investor's eyeballs ...
However, notwithstanding these challenges, from the standpoint of investment, the Indian medical device industry has remained vibrant and conducive to both ...
Read more: Covid-19: Why Indian medical device industry is in dire need to gain investor's eyeballs ...
Read more: Covid-19: Why Indian medical device industry is in dire need to gain investor's eyeballs ...
Pharma Reviews: VP of Colombia seeks deeper ties with India, bats for women empowerment - The Financial Express
Especially in the pharmaceuticals, India is very developed in this sector and ... the minister from India, he was fighting for the pharmaceutical industry.
Read more: VP of Colombia seeks deeper ties with India, bats for women empowerment - The Financial Express
Read more: VP of Colombia seeks deeper ties with India, bats for women empowerment - The Financial Express
Saturday, October 2, 2021
Pharma Reviews: Colombia's Vice President calls for joint vaccine production with India, see opportunities in ...
Maybe in the future, there will be new viruses, we would like to do research together with Indian pharma companies. Public policy for biotechnology in India ...
Read more: Colombia's Vice President calls for joint vaccine production with India, see opportunities in ...
Read more: Colombia's Vice President calls for joint vaccine production with India, see opportunities in ...
Pharma Reviews: EAM Jaishankar, visiting Colombian VP hold talks on health, pharma, biotech
“Will give impetus to our trade and investment, especially energy, IT, pharma and auto sector.” Later he also had a discussion on Indian electric vehicles with ...
Read more: EAM Jaishankar, visiting Colombian VP hold talks on health, pharma, biotech
Read more: EAM Jaishankar, visiting Colombian VP hold talks on health, pharma, biotech
Friday, October 1, 2021
US FDA News: Bayer Issues Voluntary Recall of Specific Lotrimin® and Tinactin® Spray Products Due to the Presence of Benzene
Bayer is voluntarily recalling all unexpired Lotrimin® AF and Tinactin® spray products with lot numbers beginning with TN, CV or NAA, distributed between September 2018 to September 2021, to the consumer level due to the presence of benzene in some samples of the products
Read more: Bayer Issues Voluntary Recall of Specific Lotrimin® and Tinactin® Spray Products Due to the Presence of Benzene
Read more: Bayer Issues Voluntary Recall of Specific Lotrimin® and Tinactin® Spray Products Due to the Presence of Benzene
US FDA News: Federal officials seize spices and food additive products held under insanitary conditions from a Florida warehouse
On behalf of the agency, U.S. Marshals Service conducted a mass seizure of FDA-regulated spices and food additive products held for sale under insanitary conditions that were exposed to widespread rodent infestation as well as other pests, such as live and dead insects.
Read more: Federal officials seize spices and food additive products held under insanitary conditions from a Florida warehouse
Read more: Federal officials seize spices and food additive products held under insanitary conditions from a Florida warehouse
US FDA News: Coronavirus (COVID-19) Update: October 1, 2021
Coronavirus (COVID-19) Update: October 1, 2021
Read more: Coronavirus (COVID-19) Update: October 1, 2021
Read more: Coronavirus (COVID-19) Update: October 1, 2021
US FDA News: Risk of Device Component Breaking in Patients with Stryker’s STAR Ankle: FDA Safety Communication
The FDA is informing patients, caregivers and health care providers of risk of device component breaking in patients with Stryker’s STAR Ankle Replacements.
Read more: Risk of Device Component Breaking in Patients with Stryker’s STAR Ankle: FDA Safety Communication
Read more: Risk of Device Component Breaking in Patients with Stryker’s STAR Ankle: FDA Safety Communication
Pharma Reviews: India may soon be flooded with COVID-19 pill - The Financial Express
The five companies are collaborating for the clinical trial of the investigational oral anti-viral drug Molnupiravir for the treatment of mild COVID-19 in ...
Read more: India may soon be flooded with COVID-19 pill - The Financial Express
Read more: India may soon be flooded with COVID-19 pill - The Financial Express
US FDA News: FDA to Hold Advisory Committee Meetings to Discuss Emergency Use Authorization for Booster Doses and COVID-19 Vaccines for Younger Children
The FDA is announcing two upcoming meetings of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) to discuss newly available data for the currently available COVID-19 vaccines.
Read more: FDA to Hold Advisory Committee Meetings to Discuss Emergency Use Authorization for Booster Doses and COVID-19 Vaccines for Younger Children
Read more: FDA to Hold Advisory Committee Meetings to Discuss Emergency Use Authorization for Booster Doses and COVID-19 Vaccines for Younger Children
Pharma Reviews: “Aiming for Australia-India synergistic collaboration in Life Sciences Sector” - BioSpectrum Asia
What role is the AIBX Programme playing in the healthcare and pharma sector? AIBX is a response to the 'India Economic Strategy', an ambitious plan to ...
Read more: “Aiming for Australia-India synergistic collaboration in Life Sciences Sector” - BioSpectrum Asia
Read more: “Aiming for Australia-India synergistic collaboration in Life Sciences Sector” - BioSpectrum Asia
Pharma Reviews: CPhI and Informa Pharma Intelligence concluded the 3rd Biopharma Conclave - ANI News
Owning to the inclusion of vaccines as a key part of the business portfolio by the new Indian and global pharmaceutical companies, India's vaccines industry is ...
Read more: CPhI and Informa Pharma Intelligence concluded the 3rd Biopharma Conclave - ANI News
Read more: CPhI and Informa Pharma Intelligence concluded the 3rd Biopharma Conclave - ANI News
Subscribe to:
Comments (Atom)